The biotech company is downsizing to fund another trial after a drug showed no meaningful benefit. The move comes just a year after its IPO.
Inc.com
A Biotech Company Had $268 Million in Cash. After a Failed Drug Trial, It Announced a 46 Percent Workforce Cut
Shown as published in the source's RSS feed. IndiaAIFounders doesn't link out to third-party sites — this is the complete detail available from the feed itself.